Elicio Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Elicio Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Elicio Therapeutics Inc.
Rating: 1.86550
Author: Trendlyne DVM scores

about

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigationa...

9.19 0.19 (2.11%)

148.38% Gain from 52W Low

18,992

XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

1.5 / 100

Technically Bullish

73.1 / 100

No estimates available

Elicio Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Elicio Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigationa...

148.38% Gain from 52W Low

SWOT Analysis

Elicio Therapeutics Inc. Live Price Chart